Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 75

1.

Treatment of renal congestion by tolvaptan.

Mori T, Hirose T, Kinugasa S.

Hypertens Res. 2019 May;42(5):745-748. doi: 10.1038/s41440-019-0215-9. Epub 2019 Feb 4. No abstract available.

PMID:
30718787
2.

Low-energy extracorporeal shock wave ameliorates ischemic acute kidney injury in rats.

Yoshida M, Nakamichi T, Mori T, Ito K, Shimokawa H, Ito S.

Clin Exp Nephrol. 2019 May;23(5):597-605. doi: 10.1007/s10157-019-01689-7. Epub 2019 Jan 7.

PMID:
30617840
3.

Better Healing of the Exit Site with Negative-Pressure Wound Therapy.

Mori T, Sato S, Oba-Yabana I, Hirose T, Kinugasa S, Muroya Y, Ota K, Nakayama S, Nakamura H, Tani J, Takahashi C, Ito S.

Adv Perit Dial. 2018 Nov;34(2018):53-57.

PMID:
30480539
4.

Pathophysiological and molecular mechanisms involved in renal congestion in a novel rat model.

Shimada S, Hirose T, Takahashi C, Sato E, Kinugasa S, Ohsaki Y, Kisu K, Sato H, Ito S, Mori T.

Sci Rep. 2018 Nov 14;8(1):16808. doi: 10.1038/s41598-018-35162-4.

5.

Hydrochlorothiazide ameliorates polyuria caused by tolvaptan treatment of polycystic kidney disease in PCK rats.

Wang A, Hirose T, Ohsaki Y, Takahashi C, Sato E, Oba-Yabana I, Kinugasa S, Muroya Y, Ito S, Mori T.

Clin Exp Nephrol. 2019 Apr;23(4):455-464. doi: 10.1007/s10157-018-1669-9. Epub 2018 Nov 13.

PMID:
30426292
6.

Urinary Angiotensinogen Excretion Level Is Associated With Elevated Blood Pressure in the Normotensive General Population.

Sato E, Wang AY, Satoh M, Nishikiori Y, Oba-Yabana I, Yoshida M, Sato H, Ito S, Hida W, Mori T.

Am J Hypertens. 2018 May 7;31(6):742-749. doi: 10.1093/ajh/hpy020.

PMID:
29432515
7.

Acidic organelles mediate TGF-β1-induced cellular fibrosis via (pro)renin receptor and vacuolar ATPase trafficking in human peritoneal mesothelial cells.

Oba-Yabana I, Mori T, Takahashi C, Hirose T, Ohsaki Y, Kinugasa S, Muroya Y, Sato E, Nguyen G, Piedagnel R, Ronco PM, Totsune K, Ito S.

Sci Rep. 2018 Feb 8;8(1):2648. doi: 10.1038/s41598-018-20940-x.

8.

Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS/MS and MS Imaging Techniques.

Sato E, Saigusa D, Mishima E, Uchida T, Miura D, Morikawa-Ichinose T, Kisu K, Sekimoto A, Saito R, Oe Y, Matsumoto Y, Tomioka Y, Mori T, Takahashi N, Sato H, Abe T, Niwa T, Ito S.

Toxins (Basel). 2017 Dec 28;10(1). pii: E19. doi: 10.3390/toxins10010019.

9.

Metabolic alterations by indoxyl sulfate in skeletal muscle induce uremic sarcopenia in chronic kidney disease.

Sato E, Mori T, Mishima E, Suzuki A, Sugawara S, Kurasawa N, Saigusa D, Miura D, Morikawa-Ichinose T, Saito R, Oba-Yabana I, Oe Y, Kisu K, Naganuma E, Koizumi K, Mokudai T, Niwano Y, Kudo T, Suzuki C, Takahashi N, Sato H, Abe T, Niwa T, Ito S.

Sci Rep. 2016 Nov 10;6:36618. doi: 10.1038/srep36618.

10.

Comparisons of amino acids, body constituents and antioxidative response between long-time HD and normal HD.

Torigoe A, Sato E, Mori T, Ieiri N, Takahashi C, Ishida Y, Hotta O, Ito S.

Hemodial Int. 2016 Oct;20 Suppl 1:S17-S24. doi: 10.1111/hdi.12462.

PMID:
27669544
11.

Diuretic usage for protection against end-organ damage in liver cirrhosis and heart failure.

Mori T, Ohsaki Y, Oba-Yabana I, Ito S.

Hepatol Res. 2017 Jan;47(1):11-22. doi: 10.1111/hepr.12700. Epub 2016 May 11. Review.

PMID:
26990144
12.

Urinary angiotensinogen excretion is associated with blood pressure in obese young adults.

Sato E, Mori T, Satoh M, Fujiwara M, Nakamichi Y, Oba I, Ogawa S, Kinouchi Y, Sato H, Ito S, Hida W.

Clin Exp Hypertens. 2016;38(2):203-8. doi: 10.3109/10641963.2015.1081219. Epub 2016 Jan 29.

PMID:
26825581
13.

Efficacy and Biocompatibility of Neutral Icodextrin Peritoneal Dialysis Fluid.

Shimada S, Mori T, Koizumi K, Sato S, Oba-Yabana I, Ohsaki Y, Sato E, Naganuma E, Kurasawa N, Tsuchikawa M, Ito S.

Adv Perit Dial. 2016;32:46-50.

PMID:
28988589
14.

Role of Chronic Use of Tolvaptan in Patients with Heart Failure Undergoing Peritoneal Dialysis.

Mori T, Kurasawa N, Ohsaki Y, Koizumi K, Sato S, Oba-Yabana I, Shimada S, Sato E, Naganuma E, Tsuchikawa M, Ito S.

Adv Perit Dial. 2016;32:39-45.

PMID:
28988588
15.

Association Between Home Blood Pressure and Body Composition by Bioimpedance Monitoring in Patients Undergoing Peritoneal Dialysis.

Kurasawa N, Mori T, Naganuma E, Sato E, Koizumi K, Sato S, Oba I, Tsuchikawa M, Ito S.

Adv Perit Dial. 2015;31:38-44.

PMID:
26714387
16.

Glucose and Insulin Response to Peritoneal Dialysis Fluid in Diabetic and Nondiabetic Peritoneal Dialysis Patients.

Oba I, Mori T, Chida M, Kurasawa N, Naganuma E, Sato E, Koizumi K, Sato S, Tsuchikawa M, Ito S.

Adv Perit Dial. 2015;31:11-6.

PMID:
26714381
17.

Expression of (pro)renin receptor and its upregulation by high salt intake in the rat nephron.

Rong R, Ito O, Mori N, Muroya Y, Tamura Y, Mori T, Ito S, Takahashi K, Totsune K, Kohzuki M.

Peptides. 2015 Jan;63:156-62. doi: 10.1016/j.peptides.2014.12.007. Epub 2014 Dec 31.

PMID:
25555681
18.

A functional (pro)renin receptor is expressed in human lymphocytes and monocytes.

Narumi K, Hirose T, Sato E, Mori T, Kisu K, Ishikawa M, Totsune K, Ishii T, Ichihara A, Nguyen G, Sato H, Ito S.

Am J Physiol Renal Physiol. 2015 Mar 1;308(5):F487-99. doi: 10.1152/ajprenal.00206.2014. Epub 2014 Dec 10.

19.

Elucidation of the etiology and characteristics of pink urine in young healthy subjects.

Ogawa S, Takiguchi J, Nako K, Okamura M, Sakamoto T, Kabayama S, Mori T, Kinouchi Y, Ito S.

Clin Exp Nephrol. 2015 Oct;19(5):822-9. doi: 10.1007/s10157-014-1066-y. Epub 2014 Dec 5.

PMID:
25475402
20.

Reactive oxygen species as important determinants of medullary flow, sodium excretion, and hypertension.

Cowley AW Jr, Abe M, Mori T, O'Connor PM, Ohsaki Y, Zheleznova NN.

Am J Physiol Renal Physiol. 2015 Feb 1;308(3):F179-97. doi: 10.1152/ajprenal.00455.2014. Epub 2014 Oct 29. Review.

Supplemental Content

Loading ...
Support Center